The Future Is Now: Model-Based Clinical Trial Design for Alzheimer’s Disease

Failures in trials for Alzheimer’s disease (AD) may be attributable to inadequate dosing, population selection, drug inefficacy, or insufficient design optimization. The Coalition Against Major Diseases (CAMD) was formed in 2008 to develop drug development tools (DDT) to expedite drug development fo...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Clin Pharmacol Ther
Hoofdauteurs: Romero, K, Ito, K, Rogers, JA, Polhamus, D, Qiu, R, Stephenson, D, Mohs, R, Lalonde, R, Sinha, V, Wang, Y, Brown, D, Isaac, M, Vamvakas, S, Hemmings, R, Pani, L, Bain, LJ, Corrigan, B
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: 2014
Onderwerpen:
Article
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6463482/
https://ncbi.nlm.nih.gov/pubmed/25669145
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cpt.16
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items